|Last Price||Today's Change||52-Week Range||Trading Volume|
|65.64||1.18 (+1.83%)||47.55 - 70.54||8.0 million (Above Avg)|
Market data as of 4:04PM 07/31/15. Quotes are delayed by at least 15 min.
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
07/27/2015 7:00 AM ET